Tobias Sinnberg

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

Cancers

Cells

International journal of molecular sciences

Journal of experimental & clinical cancer research : CR

University of Tübingen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tübingen Jan 01 2016

Germany

Junior group leader :: Dermatology

Publications

Simone Wendlinger, Jonas Wohlfarth, Claudia Siedel, Sophia Kreft, Teresa Kilian, Sarah Junker, Luisa Schmid, Tobias Sinnberg, Ulrich Dischinger, Markus Vincent Heppt, Kilian Wistuba-Hamprecht, Friedegund Meier, Luise Erpenbeck, Elsa Neubert, Matthias Goebeler, Anja Gesierich, David Schrama, Corinna Kosnopfel, Bastian Schilling
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils. Cancers 16 (9) (2024)
Zhe Peng, Bernhard F Gillissen, Antje Richter, Tobias Sinnberg, Max S Schlaak, Jürgen Eberle
Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x L /Bcl-w Inhibitors. International journal of molecular sciences 25 (6) (2024)
Simone Wendlinger, Jonas Wohlfarth, Claudia Siedel, Sophia Kreft, Teresa Kilian, Sarah Junker, Luisa Schmid, Tobias Sinnberg, Ulrich Dischinger, Markus Vincent Heppt, Kilian Wistuba-Hamprecht, Friedegund Meier, Luise Erpenbeck, Elsa Neubert, Matthias Goebeler, Anja Gesierich, David Schrama, Corinna Kosnopfel, Bastian Schilling
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils. Cancers 16 (9) (2024)
Zhe Peng, Bernhard F Gillissen, Antje Richter, Tobias Sinnberg, Max S Schlaak, Jürgen Eberle
Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x L /Bcl-w Inhibitors. International journal of molecular sciences 25 (6) (2024)
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, Simon Riel, Barbara Schörg, Nicolas Casadei, Manfred Kneilling, Martin Schaller, Lukas Flatz, Boris Macek, Thomas Eigentler, Olaf Rieß, Claus Garbe, Teresa Amaral, Tobias Sinnberg
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, Simon Riel, Barbara Schörg, Nicolas Casadei, Manfred Kneilling, Martin Schaller, Lukas Flatz, Boris Macek, Thomas Eigentler, Olaf Rieß, Claus Garbe, Teresa Amaral, Tobias Sinnberg
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, Simon Riel, Barbara Schörg, Nicolas Casadei, Manfred Kneilling, Martin Schaller, Lukas Flatz, Boris Macek, Thomas Eigentler, Olaf Rieß, Claus Garbe, Teresa Amaral, Tobias Sinnberg
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Zhe Peng, Bernhard F Gillissen, Antje Richter, Tobias Sinnberg, Max S Schlaak, Jürgen Eberle
Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x L /Bcl-w Inhibitors. International journal of molecular sciences 25 (6) (2024)
Markus Burkard, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M Lauer, Christian Busch, Tobias Sinnberg, Sascha Venturelli
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 12 (2) (2023)
Markus Burkard, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M Lauer, Christian Busch, Tobias Sinnberg, Sascha Venturelli
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 12 (2) (2023)
Markus Burkard, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M Lauer, Christian Busch, Tobias Sinnberg, Sascha Venturelli
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 12 (2) (2023)
Heike Niessner, Anna Hüsch, Corinna Kosnopfel, Matthias Meinhardt, Dana Westphal, Friedegund Meier, Bastian Schilling, Tobias Sinnberg
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma. Cancers 15 (23) (2023)
Lisa Marie Fröhlich, Heike Niessner, Birgit Sauer, Sofie Kämereit, Eftychia Chatziioannou, Simon Riel, Tobias Sinnberg, Birgit Schittek
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo . Cancer research communications 3 (9) (2023)
Heike Niessner, Markus Burkard, Christian Leischner, Olga Renner, Sarah Plöger, Francisco Meraz-Torres, Matti Böcker, Constanze Hirn, Ulrich M Lauer, Sascha Venturelli, Christian Busch, Tobias Sinnberg
Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells 11 (7) (2022)
Caterina Iuliano, Magdalena Absmaier-Kijak, Tobias Sinnberg, Nils Hoffard, Miriam Hils, Martin Köberle, Florian Wölbing, Ekaterina Shumilina, Nicole Heise, Birgit Fehrenbacher, Martin Schaller, Florian Lang, Susanne Kaesler, Tilo Biedermann
Fetal Tissue-Derived Mast Cells (MC) as Experimental Surrogate for In Vivo Connective Tissue MC. Cells 11 (6) (2022)
Uly Sumarni, Jiaqi Zhu, Tobias Sinnberg, Jürgen Eberle
Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression. International journal of molecular sciences 23 (20) (2022)
Tobias Sinnberg, Christa Lichtensteiger, Katharina Hill-Mündel, Christian Leischner, Heike Niessner, Christian Busch, Olga Renner, Nina Wyss, Lukas Flatz, Ulrich M Lauer, Ludwig E Hoelzle, Donatus Nohr, Markus Burkard, Luigi Marongiu, Sascha Venturelli
Vitamin C Deficiency in Blood Samples of COVID-19 Patients. Antioxidants (Basel, Switzerland) 11 (8) (2022)
Marisa Schmitt, Tobias Sinnberg, Heike Niessner, Andrea Forschner, Claus Garbe, Boris Macek, Nicolas C Nalpas
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy. Cancers 13 (21) (2021)
Annie Lauer, Markus Burkard, Heike Niessner, Christian Leischner, Olga Renner, Claudia Vollbracht, Holger Michels, Christian Busch, Tobias Sinnberg, Sascha Venturelli
Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model. Nutrients 13 (7) (2021)
Elena Makino, Lisa Marie Fröhlich, Tobias Sinnberg, Corinna Kosnopfel, Birgit Sauer, Claus Garbe, Birgit Schittek
Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition. Cell death & disease 11 (7) (2020)
Franz J Hilke, Tobias Sinnberg, Axel Gschwind, Heike Niessner, German Demidov, Teresa Amaral, Stephan Ossowski, Irina Bonzheim, Martin Röcken, Olaf Riess, Claus Garbe, Christopher Schroeder, Andrea Forschner
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 12 (9) (2020)
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, Heike Niessner, Alina Muenchow, Birgit Fehrenbacher, Martin Schaller, Peter R Mertens, Claus Garbe, Basant Kumar Thakur, Birgit Schittek
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion. Cancers 12 (8) (2020)
Teresa Amaral, Martin Schulze, Tobias Sinnberg, Maike Nieser, Peter Martus, Florian Battke, Claus Garbe, Saskia Biskup, Andrea Forschner
Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy? Cancers 12 (5) (2020)
Ellen Brenner, Barbara F Schörg, Fatima Ahmetlić, Thomas Wieder, Franz Joachim Hilke, Nadine Simon, Christopher Schroeder, German Demidov, Tanja Riedel, Birgit Fehrenbacher, Martin Schaller, Andrea Forschner, Thomas Eigentler, Heike Niessner, Tobias Sinnberg, Katharina S Böhm, Nadine Hömberg, Heidi Braumüller, Daniel Dauch, Stefan Zwirner, Lars Zender, Dominik Sonanini, Albert Geishauser, Jürgen Bauer, Martin Eichner, Katja J Ottmüller, Andreas Beilhack, Saskia Biskup, Dennis Döcker, Dirk Schadendorf, Leticia Quintanilla-Martinez, Bernd J Pichler, Manfred Kneilling, Ralph Mocikat, Martin Röcken
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours. Nature communications 11 (1) (2020)
Francisco Meraz-Torres, Sarah Plöger, Claus Garbe, Heike Niessner, Tobias Sinnberg
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos? Cancers 12 (12) (2020)
Andrea Forschner, Stephanie Weißgraeber, Dirk Hadaschik, Martin Schulze, Maria Kopp, Sabine Kelkenberg, Tobias Sinnberg, Claus Garbe, Saskia Biskup, Florian Battke
Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study. OncoTargets and therapy 13 (2020)
Marisa Schmitt, Tobias Sinnberg, Nicolas C Nalpas, Annika Maass, Birgit Schittek, Boris Macek
Quantitative Proteomics Links the Intermediate Filament Nestin to Resistance to Targeted BRAF Inhibition in Melanoma Cells. Molecular & cellular proteomics : MCP 18 (6) (2019)
Tobias Sinnberg, Mitchell P Levesque, Jelena Krochmann, Phil F Cheng, Kristian Ikenberg, Francisco Meraz-Torres, Heike Niessner, Claus Garbe, Christian Busch
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype. Molecular cancer 17 (1) (2018)
Tobias Sinnberg, Heike Niessner, Mitchell P Levesque, Christoph Dettweiler, Claus Garbe, Christian Busch
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells. Biology open 7 (6) (2018)

Tobias Sinnberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tobias Sinnberg